XNAS · QCLS
+13.89% · +$0.1100 · Vol 7.4M
After hours · updated 16:32:28 ET
Q/C Technologies, Inc. Common Stock

Q/C Technologies, Inc. Common Stock

IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES
$0.8937
Card
Relationship Map

Follow $QCLS

One email when a member of Congress discloses a trade in it, with the official filing receipt linked.

Free. No account. Unsubscribe in one click.

Follow $QCLS by email

Veridion Score

BETALOW CONF · 4 of 6 factors measuredMethodology
Earnings absence reason unknown · Analyst data unavailable at compute time
QCLS
Q/C Technologies, Inc. Common Stock
Tue Sep 22 · session closed · Markets closed · resumes Wed 9:30 ET
Middle range

Highest qualified requires a score of at least 75 and high confidence, including full factor coverage. Upper range can hold a higher score with lower confidence.

Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.

55/ 100
Veridion Score
Middle range · LOW confidence · 4 of 6 factors measured
Sovereign · $25/mo
See why this score moved.
  • · Factor breakdown with raw signals
  • · Day-over-day delta + driver
  • · Factor coverage readout
  • · Valuation · hype · market flow
  • · Pro Chart event markers
  • · Score history + alerts
Start Sovereign · $25/mo →
Cancel anytime · or Reserve · $79/mo
Confidence: LOW · 4 of 6 factors measured · Tue Sep 22 · session closed · Markets closed · resumes Wed 9:30 ET
Share on X →
Veridion Score History · 90D
Loading score history
AI Analysis
Sovereign

Why is QCLS moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.
Loading QCLS catalysts
About Q/C Technologies, Inc. Common Stock
IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES
Listed since
2021
Employees
2
Country
US

Q/C Technologies Inc is engaged in building blockchain and cryptocurrency infrastructure that is faster and more energy-efficient through quantum-class laser-based computing. The company uses laser-based processors inspired by quantum technology that can solve complex problems. By combining photonic computing with cryptocurrency systems, the company creates powerful and sustainable solutions for the next generation of blockchain applications.

Company website →
Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

Open
$0.7770
Day high
$1.02
Day low
$0.7672
Previous close
$0.7847
52W high
$6.92
-87.09% from high
52W low
$0.4413
7% of range
Market cap
$6.4M
P/E
0.34×
EPS
$2.63
Beta
2.69
Shares out
8.2M
Volume
7.4M
0.80× rel vol
Avg volume
9.3M
VWAP
$0.9142
Price history computed in-house
1W
+102.52%
1M
-65.36%
3M
-76.54%
1Y
-80.98%
YTD
-77.60%
SMA 50 $2.41 · below
SMA 200 $3.68 · below
52W position 7%

QCLS overview

Veridion Score
55
Registered · 2026-09-22
4 of 6 factors measured
Latest receipt rows
0
No recent disclosure on file.
13F holders
None on file

Related filings and maps

Relationship mapTrace receipt-backed holders and filings around QCLS.Congress trackerSearch the public STOCK Act disclosure ledger.MethodologyReview score inputs, coverage rules, and limitations.
Loading financial statements
Loading QCLS Form 4 filings
Public disclosures

Congress activity in QCLS

Congress trackerOpen ticker disclosure ledger →

No receipt-qualified Congressional disclosure is present for QCLS in the cached public ledger.

Federal contracts

QCLS contract awards, year to date.

Public federal awards linked to this ticker.

Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for QCLS in this window.
Lobbying spend

QCLS lobbying filings, year to date.

Registered lobbying filings matched to Q/C Technologies, Inc. Common Stock.

Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for QCLS in this window.
Loading news for QCLS
Analyst ratings
Sovereign unlock shows live analyst consensus for QCLS.
Options
Sovereign unlock shows live options positioning for QCLS.
Weekly Veridion brief

Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.